News

Jab Well Done: 340 ParScians Acquire their COVID-19 Doses

by Denise Fundal

June 19, 2022

On November 8, 2021, various vaccination sites in Paranaque assisted teenagers in acquiring their doses of COVID-19. This is in light of the Department of Health’s confirmation in September 2021 that a nationwide vaccination rollout for 12 to 17 years old will take place.

An expected 2,000 doses have been set to be administered at Ayala Malls Manila Bay and every other 1,500 at SM City Sucat, which have been vaccination sites for minors aged 12-17.

Among those who got their jab that day were 340 ParScians who received their doses together with other Paranaque students from different schools in the area.

The students have been waiting in long queues while maintaining social distancing along with their face masks and face shields to ensure that vaccination is safe and smooth even when there is a large range of minors in the said sites.

“The moment before I got vaccinated, I was really nervous and excited at the same time. Now I feel at least safe because I now have protection against COVID-19, though I know that it’s not very effective to block the virus. And when I finally got vaccinated, it was really fun, and I didn’t feel a thing. Even though it was only the first dose, I am still happy because I got the chance to be vaccinated.” said Corazon D. Silangcruz, A 9th-grade ParScian who was one of the successful recipients of the dose that day.

According to the Department of Health, 31,298,395 booster vaccines have been administered to people in various parts of the Philippines, 68,119,446 for the first dose of the COVID-19 vaccine and 73,639,367 for the second dose.

Pain, headache, tenderness, swelling on the arm where you got the injection, feeling feverish, and muscle ache are the most common possible side effects after receiving a COVID-19 vaccine.

As health experts and DOH encourage everyone to get vaccinated, vaccination rollouts are still ongoing in different places in the Philippines. This is to achieve herd immunity amidst certain threats by COVID-19 and its variants.